COMBINATION OF LIGAND-BASED PHARMACOPHORE MODELLING, MOLECULAR DYNAMICS, AND DEEP LEARNING APPROACH TO IDENTIFY SELECTIVE PANK INHIBITORS AS ANTITUBERCULAR AGENTS

被引：0
|
作者：
Jha, P. [1 ]
Chopra, M. [1 ]
机构：
[1] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi, India
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2023年 / 130卷
关键词：
D O I：
10.1016/j.ijid.2023.04.020
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [41] Ligand-Based Virtual Screening and Molecular Docking Studies to Identify the Critical Chemical Features of Potent Cathepsin D Inhibitors
    Sakkiah, Sugunadevi
    Thangapandian, Sundarapandian
    Lee, Keun Woo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (01) : 64 - 80
  • [42] Ligand-based 3D pharmacophore design, virtual screening and molecular docking for novel p38 MAPK inhibitors
    Lijuan He
    Ru Dai
    Xuan R. Zhang
    Si Y. Gao
    Yan Y. He
    Li B. Wang
    Xang Gao
    Lu Q. Yang
    Medicinal Chemistry Research, 2015, 24 : 797 - 809
  • [43] Ligand-based 3D pharmacophore design, virtual screening and molecular docking for novel p38 MAPK inhibitors
    He, Lijuan
    Dai, Ru
    Zhang, Xuan R.
    Gao, Si Y.
    He, Yan Y.
    Wang, Li B.
    Gao, Xang
    Yang, Lu Q.
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (02) : 797 - 809
  • [44] Identification of potent histone deacetylase 2 (HDAC2) inhibitors through combined structure and ligand-based designs and molecular modelling approach
    Anand, Asha
    Ghosh, Powsali
    Singh, Ravi
    Bajad, Nilesh Gajanan
    Kumar, Ashok
    Singh, Sushil Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, : 4679 - 4698
  • [45] A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation
    Thakur, Shikha
    Sinhari, Apurba
    Gaikwad, Anil Bhanudas
    Jadhav, Hemant R.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 756
  • [46] Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions
    Ja'afaru, Saudatu Chinade
    Uzairu, Adamu
    Bayil, Imren
    Sallau, Muhammed Sani
    Ndukwe, George Iloegbulam
    Ibrahim, Muhammad Tukur
    Moin, Abu Tayab
    Mollah, A. K. M. Moniruzzaman
    Absar, Nurul
    PLOS ONE, 2024, 19 (06):
  • [47] Identification of HDAC6 selective inhibitors: pharmacophore based virtual screening, molecular docking and molecular dynamics simulation
    Yan, Guoyi
    Li, Dongxiao
    Zhong, Xinxin
    Liu, Ge
    Wang, Xueqin
    Lu, Yuanxiang
    Qin, Fangyuan
    Guo, Yuqi
    Duan, Shaofeng
    Li, Deyu
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (06): : 1928 - 1939
  • [48] Ligand-based virtual screening, molecular dynamics, and biological evaluation of repurposed drugs as inhibitors of Trypanosoma cruzi proteasome
    Gomes, Suzane Quintana
    Federico, Leonardo Bruno
    Silva, Guilherme Martins
    Lopes, Carla Duque
    de Albuquerque, Sergio
    da Silva, Carlos Henrique Tomich de Paula
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (23): : 13844 - 13856
  • [49] Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents
    Vazquez-Jimenez, Lenci K.
    Juarez-Saldivar, Alfredo
    Gomez-Escobedo, Rogelio
    Delgado-Maldonado, Timoteo
    Mendez-Alvarez, Domingo
    Palos, Isidro
    Bandyopadhyay, Debasish
    Gaona-Lopez, Carlos
    Ortiz-Perez, Eyra
    Nogueda-Torres, Benjamin
    Ramirez-Moreno, Esther
    Rivera, Gildardo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [50] Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 Mpro inhibitors
    Mohamed, Nada M.
    Ali, Eslam M. H.
    AboulMagd, Asmaa M.
    RSC ADVANCES, 2021, 11 (08) : 4523 - 4538
12345